Aurora cannabis announces collaboration on genome bc-funded project addressing distinct cannabis aromas

Nasdaq | tsx: acb research project designed to validate breeding genetics connected with fruity aroma, a key patient and consumer preference trait, with positive impact on future innovation  edmonton, ab , oct. 2, 2024 /prnewswire/ - aurora cannabis inc. (nasdaq: acb) (tsx: acb) –—the canadian based leading global medical cannabis company, today announced a research grant provided to the university of british columbia (ubc) by genome british columbia (genome bc), a not-for-profit organization supporting world-class genomics research and innovation in british columbia. the project, genomics-enabled aroma breeding in cannabis, will directly support aurora's genetics work the project, is led by drs.
ACB Ratings Summary
ACB Quant Ranking